The company intends to use the net proceeds from the offering for working capital, general corporate purposes, and expenses relating to the merger with Kadimastem Ltd.
Company Description
NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.